Literature DB >> 23422739

Adipokines in obesity.

Viviane de Oliveira Leal1, Denise Mafra.   

Abstract

White adipose tissue is recognized as a dynamic endocrine organ able to produce and release several bioactive polypeptides known as adipokines. Obesity is defined as an excessive growth of adipose tissue. As such, it is likely that adipokines could play an important role in the development of diseases associated with obesity including insulin resistance, inflammation, hypertension, cardiovascular risk and metabolic disorders. This review focuses on obesity specific-adipokine profiles and the role of some adipokines in obesity-related metabolic disorders.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23422739     DOI： 10.1016/j.cca.2013.02.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  87 in total

Review 1.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

Review 2.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

3.  Laparoscopic adjustable gastric banding reduces subcutaneous adipose tissue and blood inflammation in nondiabetic morbidly obese individuals.

Authors:  Laura Iaffaldano; Carmela Nardelli; Vincenzo Pilone; Giuseppe Labruna; Andreina Alfieri; Donatella Montanaro; Maddalena Ferrigno; Maria Restituta Zeccolella; Nicola Carlomagno; Andrea Renda; Alfonso Baldi; Pietro Forestieri; Lucia Sacchetti; Pasqualina Buono
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

4.  Independent positive association of plasma β-carotene concentrations with adiponectin among non-diabetic obese subjects.

Authors:  N Ben Amara; F Tourniaire; M Maraninchi; N Attia; M J Amiot-Carlin; D Raccah; R Valéro; J F Landrier; P Darmon
Journal:  Eur J Nutr       Date:  2014-06-07       Impact factor: 5.614

5.  Low-Grade Inflammation, Obesity, and Diabetes.

Authors:  Solange S Pereira; Jacqueline I Alvarez-Leite
Journal:  Curr Obes Rep       Date:  2014-12

6.  Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Gema Frühbeck
Journal:  Genes Nutr       Date:  2015-04-14       Impact factor: 5.523

Review 7.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06

8.  Anthocyanins regulate serum adipsin and visfatin in patients with prediabetes or newly diagnosed diabetes: a randomized controlled trial.

Authors:  Liping Yang; Yun Qiu; Wenhua Ling; Zhaomin Liu; Lili Yang; Changyi Wang; Xiaolin Peng; Li Wang; Jianying Chen
Journal:  Eur J Nutr       Date:  2020-09-15       Impact factor: 5.614

9.  Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease.

Authors:  O Osorio-Conles; M Guitart; J M Moreno-Navarrete; X Escoté; X Duran; J M Fernandez-Real; A M Gomez-Foix; S Fernández-Veledo; J Vendrell
Journal:  Mol Med       Date:  2017-08-23       Impact factor: 6.354

Review 10.  Physiological and pathological impact of exosomes of adipose tissue.

Authors:  Yan Zhang; Mei Yu; Weidong Tian
Journal:  Cell Prolif       Date:  2016-01-18       Impact factor: 6.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.